Mass Tort Defense: 3 Critical Risks Companies Must Prepare for

Mass tort defense involves coordination among multiple defendants, plaintiffs, and courts in ways that single-case litigation does not require. In a mass tort context, a single product defect, pharmaceutical side effect, or environmental release can generate hundreds or thousands of similar injury claims, each with its own plaintiff but often sharing common questions of fact and law.

Federal courts have developed the MDL process to centralize pretrial proceedings when multiple civil actions arise from a common nucleus of operative fact. This consolidation can dramatically accelerate discovery, expert disclosure, and Daubert motions, but it also concentrates judicial scrutiny and media attention. State courts in New York and elsewhere may consolidate related claims through their own procedures, creating parallel tracks that require careful coordination.

From a practitioner's perspective, the defense strategy in a mass tort differs because individual case resolution often depends on how the aggregate litigation develops. A ruling on a key scientific question, a bellwether trial outcome, or a negotiated settlement framework can influence dozens of other cases. This interdependence means that early decisions about which issues to contest, which experts to retain, and how aggressively to litigate individual cases carry implications beyond that single dispute.

Courts use several mechanisms to manage the procedural burden of mass torts. The MDL statute allows the Judicial Panel on Multidistrict Litigation to centralize pretrial proceedings in a single federal district, typically before a judge with experience managing large-scale discovery and expert disputes.

Within an MDL, the court often establishes a case management protocol that includes staged discovery, phased expert disclosure, and coordinated motion practice. This structure can reduce duplicative discovery and create efficiency, but it also means that defense counsel must coordinate with co-defendants, insurance carriers, and in-house teams across multiple companies or entities. In New York state court mass torts, judges may use individual case management orders and discovery protocols to prevent the litigation from becoming unmanageable, though coordination is typically less formal than in federal MDLs.

The procedural framework also creates opportunities for early motion practice. Defendants often file motions to dismiss, motions to sever claims, or Daubert challenges to expert testimony at the pretrial stage. These motions can narrow the scope of litigation significantly, but they require careful factual development and expert rebuttal work early in the case lifecycle.

Settlement in mass torts operates differently than in single-plaintiff cases because the defense must often negotiate a global resolution that addresses the entire plaintiff population or a substantial portion of it. This creates pressure to establish settlement criteria early, such as injury classification systems, damage caps, or payment algorithms that apply across hundreds of cases.

Defense counsel must evaluate whether to pursue individual trial victories, seek bellwether trials to test liability and damages theories, or move toward a structured settlement framework. Each approach carries different risk profiles. Litigation to judgment can establish favorable precedent but also risks adverse verdicts that influence other pending cases. Settlement negotiations, by contrast, offer predictability and cost containment but require agreement on valuation metrics that may not align with individual case merit.

Practitioners often advise early engagement with plaintiffs' counsel and mediators to explore settlement parameters before discovery becomes expensive and positions harden. The timing of these discussions matters significantly because information developed during discovery—expert reports, document productions, deposition testimony—can shift settlement leverage substantially.

Preparation for potential mass tort exposure begins long before litigation is filed. Defendants should maintain comprehensive records of product design decisions, testing protocols, internal risk assessments, and regulatory compliance documentation. These records become critical evidence in mass tort defense because they demonstrate the reasonableness of the defendant's conduct and decision-making process.

A related practice area, mass torts, involves managing coordinated defense across multiple claims. Early preparation also includes identifying and preserving expert witnesses who can testify about industry standards, product safety, causation, and damages methodology. Insurance carriers should be notified promptly so that coverage counsel can evaluate policy limits and defense obligations.

Documentation of the defendant's response to any notice of potential injury or defect is also crucial. Courts examine how quickly a defendant investigated complaints, whether warnings or recalls were considered, and what internal communications occurred. In jurisdictions like New York, courts may examine the timeliness and completeness of a defendant's initial investigation and disclosure to regulators. Incomplete or delayed documentation can create an inference of consciousness of guilt, even if the underlying conduct was reasonable.

Mass torts often involve multiple defendants with divergent interests. A manufacturer, a distributor, and a retailer may all face liability for the same product injury, but their defenses and settlement positions may conflict. Similarly, co-manufacturers of a component may disagree about who bears primary responsibility for a design defect.

Defense counsel must navigate these conflicts carefully. Some jurisdictions allow defendants to enter into non-collusion agreements that permit limited communication and coordination while preserving each defendant's independent legal strategy. Other contexts require separate counsel for each defendant to avoid conflicts of interest. The choice depends on the specific factual circumstances, insurance arrangements, and court rules governing the particular litigation.

In practice, coordination often occurs through joint defense agreements, which permit defense counsel to share work product and strategy while maintaining each defendant's independent litigation posture. These agreements require careful drafting to ensure that communications remain privileged and that no defendant is disadvantaged by shared information. Defendants should also consider whether to retain common experts or separate experts, how to allocate discovery costs, and whether to pursue joint or separate settlement discussions.

A related defense practice, federal extortion defense, involves managing coordinated legal strategy in complex scenarios. Similarly, mass tort defense requires early clarity about each defendant's role, exposure, and settlement authority so that counsel can develop an efficient and coherent litigation strategy.

Moving forward, defendants should prioritize early retention of experienced mass tort counsel, preservation of all potentially relevant documents and communications, coordination with insurance carriers on coverage and defense funding, and realistic assessment of liability exposure based on the specific product, injury allegations, and applicable law. These steps do not guarantee any particular outcome, but they create a foundation for informed decision-making as the litigation develops and settlement opportunities emerge.